prednisone has been researched along with Extranodal NK-T-Cell Lymphoma in 38 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Thirty patients were treated with the study regimen, consisting of alemtuzumab on day 1 of a 21 day cycle with standard dosing of DA-EPOCH for 6-8 cycles." | 2.90 | Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas. ( Jaffe, ES; Lucas, A; Melani, C; Pittaluga, S; Roschewski, M; Roswarski, J; Steinberg, SM; Waldmann, TA; Wilson, WH, 2019) |
| " The major adverse effects were bone marrow suppression, reduction of fibrinogen level, liver dysfunction, and digestive tract toxicities." | 2.87 | PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity. ( Deng, L; Gao, Y; Ke, X; Lin, N; Liu, W; Ping, L; Ren, H; Song, Y; Su, L; Tu, M; Wang, X; Xie, Y; Ying, Z; Zhang, C; Zhang, W; Zheng, W; Zhu, J, 2018) |
| "A 53-year-old man with systemic lupus erythematosus who was receiving chronic low-dose prednisone treatment developed proptosis of the right eye." | 1.35 | Third cranial nerve palsy caused by intracranial extension of a sino-orbital natural killer T-cell lymphoma. ( Chen, CS; Eberhart, C; Lane, A; Miller, NR, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.63) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (21.05) | 29.6817 |
| 2010's | 28 (73.68) | 24.3611 |
| 2020's | 1 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, C | 1 |
| Wang, Y | 1 |
| Cao, J | 1 |
| Sun, X | 1 |
| He, X | 1 |
| Sun, P | 1 |
| Gao, T | 1 |
| Huang, J | 1 |
| Li, Z | 1 |
| Tomoka, T | 1 |
| Powers, E | 1 |
| van der Gronde, T | 1 |
| Amuquandoh, A | 1 |
| Dhungel, BM | 1 |
| Kampani, C | 1 |
| Kamiza, S | 1 |
| Montgomery, ND | 1 |
| Fedoriw, Y | 1 |
| Gopal, S | 1 |
| Su, YJ | 1 |
| Wang, PN | 1 |
| Chang, H | 1 |
| Shih, LY | 1 |
| Lin, TL | 1 |
| Kuo, MC | 1 |
| Chuang, WY | 1 |
| Wu, JH | 1 |
| Tang, TC | 1 |
| Hung, YS | 1 |
| Dunn, P | 1 |
| Kao, HW | 1 |
| Zheng, W | 2 |
| Gao, Y | 1 |
| Ke, X | 1 |
| Zhang, W | 5 |
| Su, L | 1 |
| Ren, H | 2 |
| Lin, N | 1 |
| Xie, Y | 1 |
| Tu, M | 1 |
| Liu, W | 2 |
| Ping, L | 1 |
| Ying, Z | 1 |
| Zhang, C | 1 |
| Deng, L | 1 |
| Wang, X | 1 |
| Song, Y | 2 |
| Zhu, J | 2 |
| Roswarski, J | 1 |
| Roschewski, M | 1 |
| Melani, C | 1 |
| Pittaluga, S | 1 |
| Lucas, A | 1 |
| Steinberg, SM | 1 |
| Jaffe, ES | 1 |
| Waldmann, TA | 1 |
| Wilson, WH | 1 |
| Wang, L | 2 |
| Wang, WD | 1 |
| Xia, ZJ | 3 |
| Zhang, YJ | 3 |
| Xiang, J | 1 |
| Lu, Y | 3 |
| Liu, QF | 3 |
| Wang, WH | 3 |
| Wang, SL | 3 |
| Liu, YP | 3 |
| Huang, WT | 1 |
| Lu, N | 1 |
| Zhou, LQ | 2 |
| Ouyang, H | 1 |
| Jin, J | 4 |
| Li, YX | 4 |
| Wang, H | 3 |
| Wuxiao, ZJ | 1 |
| Wang, Z | 1 |
| Wang, KF | 1 |
| Li, S | 1 |
| Chen, X | 1 |
| Yuan, F | 1 |
| Wei, X | 1 |
| Yin, Q | 1 |
| Li, Y | 1 |
| Mi, R | 1 |
| Ai, H | 1 |
| Yang, H | 1 |
| Li, H | 2 |
| Ge, S | 1 |
| Liu, Y | 2 |
| Vasconcelos, Pd | 1 |
| Ferreira, C | 1 |
| Soares-Almeida, L | 1 |
| Filipe, P | 1 |
| Wan, WL | 1 |
| Wang, J | 2 |
| Zhu, MX | 1 |
| Ke, XY | 1 |
| Hu, L | 1 |
| Xu, W | 1 |
| Wang, M | 1 |
| Wang, P | 1 |
| Han, G | 1 |
| Lin, C | 1 |
| Huang, L | 1 |
| Yuan, B | 1 |
| Wu, H | 1 |
| Chu, H | 1 |
| Wu, S | 1 |
| Lu, H | 2 |
| Chen, H | 1 |
| Zhang, S | 1 |
| Leng, DN | 1 |
| Zhang, XX | 1 |
| Xie, CH | 1 |
| Xu, Y | 1 |
| Deng, D | 1 |
| Zhao, YH | 1 |
| Zou, BW | 1 |
| Zhou, L | 1 |
| Li, M | 1 |
| Liu, WP | 2 |
| Huang, MJ | 1 |
| Ma, HH | 1 |
| Qian, LT | 1 |
| Pan, HF | 1 |
| Yang, L | 2 |
| Zhang, HY | 1 |
| Wang, ZH | 1 |
| Ma, J | 1 |
| Zhao, YF | 1 |
| Gao, J | 1 |
| Wu, AD | 1 |
| Ma, X | 1 |
| Guo, Y | 1 |
| Pang, Z | 1 |
| Wang, B | 1 |
| Gu, YJ | 1 |
| Guo, X | 1 |
| Xu, G | 1 |
| Wang, HF | 1 |
| He, G | 1 |
| Xie, K | 1 |
| Wang, ZY | 2 |
| Song, YW | 2 |
| Qi, SN | 2 |
| Fang, H | 3 |
| Liu, XF | 3 |
| Yu, ZH | 3 |
| Zhang, WY | 1 |
| Li, GD | 1 |
| Wang, XJ | 1 |
| Qin, H | 1 |
| Schmitz, N | 1 |
| Trümper, L | 1 |
| Ziepert, M | 1 |
| Nickelsen, M | 1 |
| Ho, AD | 1 |
| Metzner, B | 1 |
| Peter, N | 1 |
| Loeffler, M | 1 |
| Rosenwald, A | 1 |
| Pfreundschuh, M | 1 |
| Moumine, M | 1 |
| Sabani, H | 1 |
| Qamous, W | 1 |
| Nassih, M | 1 |
| Al Bouzidi, A | 1 |
| Rzin, A | 1 |
| Huang, H | 1 |
| Lin, Z | 1 |
| Lin, X | 1 |
| Cai, Q | 1 |
| Xia, Z | 1 |
| Jiang, W | 1 |
| Jiang, M | 1 |
| Zhang, H | 2 |
| Jiang, Y | 1 |
| Yang, Q | 1 |
| Xie, L | 1 |
| Ji, X | 1 |
| Li, P | 1 |
| Chen, N | 1 |
| Zhao, S | 1 |
| Wang, F | 1 |
| Zou, L | 1 |
| Liang, ZY | 1 |
| Manley, K | 1 |
| Dunning, J | 1 |
| Nelson, M | 1 |
| Bower, M | 1 |
| Baran, AM | 1 |
| Reifenberger, J | 1 |
| Helbig, D | 1 |
| Uri, N | 1 |
| Schindler, Y | 1 |
| Quitt, M | 1 |
| Valkovsky, O | 1 |
| Barzilai, G | 1 |
| Ely, A | 1 |
| Evans, J | 1 |
| Sundstrom, JM | 1 |
| Malysz, J | 1 |
| Specht, CS | 1 |
| Wilkinson, M | 1 |
| Sang, W | 2 |
| Wang, CF | 1 |
| Cheng, YF | 1 |
| Liu, X | 1 |
| Li, XX | 2 |
| Gulinar, A | 1 |
| Li, JZ | 1 |
| Zhang, G | 1 |
| Bai, HX | 1 |
| Ma, MH | 1 |
| Su, Y | 1 |
| Luo, Y | 1 |
| Wen, H | 1 |
| Lu, Q | 1 |
| Xiao, R | 1 |
| Huang, HQ | 1 |
| Wu, RY | 1 |
| Lu, NN | 1 |
| Chen, B | 1 |
| Zhang, XM | 1 |
| Shi, XL | 1 |
| Gulinaer, A | 1 |
| Yang, WT | 1 |
| LYONNET, R | 1 |
| SAVOYE, J | 1 |
| MOREL, P | 1 |
| MICHEL, PJ | 1 |
| Yao, B | 1 |
| Zou, GR | 1 |
| Xie, FY | 1 |
| Li, HX | 1 |
| Xia, YF | 1 |
| Lin, TY | 1 |
| Lu, TX | 1 |
| Chen, CS | 1 |
| Miller, NR | 1 |
| Lane, A | 1 |
| Eberhart, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Gemcitabine, Oxaliplatin and Pegaspargase and Etoposide, Vincristine, Doxorubicin, Cyclophosphamide and Prednisone as First-line Chemotherapy in Patients With NK/T-cell Lymphoma：a Prospective Randomized Phase III Study[NCT02359162] | Phase 3 | 50 participants (Actual) | Interventional | 2015-05-31 | Terminated (stopped due to The study is out of date) | ||
| Nivolumab With Standard of Care Chemotherapy for the First Line Treatment of Peripheral T Cell Lymphoma[NCT03586999] | Phase 1/Phase 2 | 18 participants (Actual) | Interventional | 2018-11-07 | Active, not recruiting | ||
| Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.[NCT03964480] | 1,000 participants (Anticipated) | Observational [Patient Registry] | 2018-10-14 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for prednisone and Extranodal NK-T-Cell Lymphoma
| Article | Year |
|---|---|
Orbital involvement in extranodal natural killer T cell lymphoma: an atypical case presentation and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female | 2012 |
[Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD56 Antigen; Cyclophosphamid | 2012 |
9 trials available for prednisone and Extranodal NK-T-Cell Lymphoma
| Article | Year |
|---|---|
PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; Cyclophospham | 2018 |
Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami | 2019 |
Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Ad | 2010 |
A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE/IIE extranodal NK/T-cell lymphoma, nasal type in the upper aerodigestive tract.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; H | 2009 |
Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; China; Combined Modality Therapy; | 2009 |
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosph | 2010 |
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosph | 2010 |
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosph | 2010 |
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosph | 2010 |
Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha | 2011 |
Phase 2 trial of "sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Moda | 2012 |
Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclopho | 2012 |
27 other studies available for prednisone and Extranodal NK-T-Cell Lymphoma
| Article | Year |
|---|---|
Elevated expression of HMGB1 is prognostic of poor survival in patients with relapsed/refractory T/NK-CL.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; | 2021 |
Extranodal natural killer/T-cell lymphoma in Malawi: a report of three cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopsy; Cyclophosphamide; DNA, Vi | 2017 |
Extranodal NK/T-cell lymphoma, nasal type: Clinical features, outcome, and prognostic factors in 101 cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2018 |
Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term fol
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi | 2014 |
Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy | 2014 |
Comparison of gemcitabine, oxaliplatin and L-asparaginase and etoposide, vincristine, doxorubicin, cyclophosphamide and prednisone as first-line chemotherapy in patients with stage IE to IIE extranodal natural killer/T-cell lymphoma: a multicenter retrosp
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophospham | 2015 |
[A multi-center retrospective study of L-asparaginase-based regimens as first-line treatment in newly diagnosed extranodal NK/T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Doxorubicin; Female; | 2014 |
Multifocal primary cutaneous extranodal NK/T lymphoma nasal type.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Fatal O | 2016 |
[Retrospective analyses of CHOPE plus L-asparaginase regimen in treatment of T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comparative Effectiveness Research; Cy | 2016 |
A case report of primary unilateral adrenal NK/T cell lymphoma: good clinical outcome with trimodality treatment.
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; C | 2017 |
Comparative Study of L-Asparaginase-Based LOP Regimen Over CHOP Regimen Before Radiotherapy for Stage IIE Extranodal Nasal Type NK/T Cell Lymphoma: A Study of 2 Centers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi | 2017 |
[Clinicopathological observation on 2 cases of nasal-type NK/T-cell lymphoma in the esophagus].
Topics: Antineoplastic Combined Chemotherapy Protocols; CD56 Antigen; Cyclophosphamide; Doxorubicin; Esophag | 2008 |
Salvage treatment improved survival of patients with relapsed extranodal natural killer/t-cell lymphoma, nasal type.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyc | 2009 |
[Expression and significance of p53-related proteins and LMP-1 in nasal NK/T-cell lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclin-Dependent Kinase Inh | 2009 |
[Fever and splenic lesion].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CD56 Antigen; Cyclophosphamide; Doxorubicin; | 2010 |
[Maxillary T/NK lymphoma. Case report].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Ant | 2011 |
[Blastic plasmacytoid dendritic cell neoplasm: report of a case].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide; | 2011 |
HIV-associated gastric natural killer/T-cell lymphoma.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Atazanavir Sulfate; Cyclopho | 2012 |
[NK/T-cell lymphoma, nasal type with cutaneous dissemination].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubic | 2012 |
Primary NK/T-cell lymphoma of the larynx.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubi | 2012 |
NK-/T-cell lymphoma resembling hydroa vacciniforme with positive CD4 marker expression: a diagnostic difficulty.
Topics: Acyclovir; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; CD4 Ant | 2013 |
Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2014 |
[Clinicopathologic study of 20 cases of anaplastic large-cell lymphoma].
Topics: Adolescent; Adult; Aged; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; | 2012 |
[Congenital malignant histiomonocytic reticulosis].
Topics: Child; Histiocytic Sarcoma; Histiocytosis, Langerhans-Cell; Infant; Lymphoma, Extranodal NK-T-Cell; | 1961 |
[Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Topics: Adolescent; Adult; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 2006 |
[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2006 |
Third cranial nerve palsy caused by intracranial extension of a sino-orbital natural killer T-cell lymphoma.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Epstein-Barr | 2008 |